Alzheimer disease, the two-hit hypothesis: an update.

Given the relative modality of single-insult models to accurately reflect Alzheimer disease pathogenesis, based on studies on mitogenic and oxidative stress signaling pathways, we proposed a two-hit hypothesis 2 years ago stating that both oxidative stress and mitogenic dysregulation are necessary and sufficient to cause the disease and suggested that it may be a common mechanism for other neurodegenerative diseases as well (X. Zhu, A.K. Raina, G. Perry, M.A. Smith, Alzheimer's disease: the two-hit hypothesis, Lancet Neurol. 3 (2004) 219-226). Recent developments in the field confirm some important predictions of the hypothesis and shed new lights on potential mechanisms regarding how steady state may be achieved in sporadic AD cases and therefore, in our opinion, strengthen the hypothesis, which will be the focus of this review.

[1]  J. Loike,et al.  Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils , 1996, Nature.

[2]  W. Markesbery,et al.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  W. D. Ehmann,et al.  Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.

[4]  A. Roses.  On the metabolism of apolipoprotein E and the Alzheimer diseases , 1995, Experimental Neurology.

[5]  J. Loike,et al.  Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. , 1996, Nature.

[6]  David S. Park,et al.  Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal Death* , 1999, The Journal of Biological Chemistry.

[7]  J. Zweier,et al.  Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide , 1995, Nature Medicine.

[8]  P. Coleman,et al.  Neurons may live for decades with neurofibrillary tangles. , 1999, Journal of neuropathology and experimental neurology.

[9]  A. Bradley,et al.  Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis , 1992, Nature.

[10]  M. Smith,et al.  Early glycoxidation damage in brains from Down's syndrome. , 1998, Biochemical and biophysical research communications.

[11]  C. Culmsee,et al.  Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer’s disease , 1999, Journal of Molecular Neuroscience.

[12]  G. Perry,et al.  Do neurons have a choice in death? , 2001, The American journal of pathology.

[13]  Wen-Lang Lin,et al.  Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein , 2000, Nature Genetics.

[14]  William M. Mauck,et al.  Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice , 2004, Journal of neurochemistry.

[15]  M. Smith,et al.  Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.

[16]  David S. Park,et al.  Multiple Pathways of Neuronal Death Induced by DNA-Damaging Agents, NGF Deprivation, and Oxidative Stress , 1998, The Journal of Neuroscience.

[17]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[18]  M. Mattson,et al.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Hyoung-Gon Lee,et al.  Oxidative imbalance in alzheimer’s disease , 2007, Molecular Neurobiology.

[20]  X. Chen,et al.  RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.

[21]  David S. Park,et al.  Cyclin Dependent Kinase Inhibitors and Dominant Negative Cyclin Dependent Kinase 4 and 6 Promote Survival of NGF-Deprived Sympathetic Neurons , 1997, The Journal of Neuroscience.

[22]  P. Hof,et al.  Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms , 2005, The Journal of Neuroscience.

[23]  A. Nunomura,et al.  Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease , 2004, Neurobiology of Disease.

[24]  X. Graña,et al.  Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). , 1995, Oncogene.

[25]  Visith Thongboonkerd,et al.  Proteomic identification of nitrated proteins in Alzheimer's disease brain , 2003, Journal of neurochemistry.

[26]  C. Lippa,et al.  Ki‐67 Immunoreactivity in Alzheimer's Disease and Other Neurodegenerative Disorders , 1995, Journal of neuropathology and experimental neurology.

[27]  D. Bennett,et al.  Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment , 2006, Neurobiology of Aging.

[28]  D. Butterfield,et al.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. , 2001, Trends in molecular medicine.

[29]  Hyoung-Gon Lee,et al.  Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. , 2007, Biochimica et biophysica acta.

[30]  J. Shulman,et al.  TOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy Model , 2006, Current Biology.

[31]  W. Markesbery,et al.  Elevated Zinc Transporter-6 in Mild Cognitive Impairment, Alzheimer Disease, and Pick Disease , 2006, Journal of neuropathology and experimental neurology.

[32]  G. Perry,et al.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Xiongwei Zhu,et al.  JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease , 2003, Journal of neurochemistry.

[34]  George Perry,et al.  Increased p27, an essential component of cell cycle control, in Alzheimer's disease , 2003, Aging cell.

[35]  Mark A. Smith,et al.  Advanced Maillard Reaction End Products, Free Radicals, and Protein Oxidation in Alzheimer's Disease a , 1994, Annals of the New York Academy of Sciences.

[36]  Xiongwei Zhu,et al.  Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes , 2000, Neurobiology of Aging.

[37]  W. Markesbery,et al.  Four-Hydroxynonenal, a Product of Lipid Peroxidation, is Increased in the Brain in Alzheimer’s Disease , 1998, Neurobiology of Aging.

[38]  Xiongwei Zhu,et al.  Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease , 2000, Neurobiology of Aging.

[39]  C. W. Scott,et al.  Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  F. Delalande,et al.  Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis , 2007, Neurobiology of Aging.

[41]  Xiongwei Zhu,et al.  Mitochondrial failures in Alzheimer's disease , 2004, American journal of Alzheimer's disease and other dementias.

[42]  P Woodbury,et al.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. , 1997, The New England journal of medicine.

[43]  Xiongwei Zhu,et al.  Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the ‘two hit’ hypothesis , 2001, Mechanisms of Ageing and Development.

[44]  George Perry,et al.  The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease , 2002, Neurosignals.

[45]  G. Perry,et al.  Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? , 2003, Acta Neuropathologica.

[46]  Xiongwei Zhu,et al.  Alzheimer's disease: the two-hit hypothesis , 2004, The Lancet Neurology.

[47]  M. Beal,et al.  Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[48]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.

[49]  Kevin M. Brown,et al.  Gene expression correlates of neurofibrillary tangles in Alzheimer's disease , 2006, Neurobiology of Aging.

[50]  P. Cras,et al.  Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. , 1990, The American journal of pathology.

[51]  P. Lantos,et al.  Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.

[52]  J. M. Davies,et al.  Transient adaptation to oxidative stress in yeast. , 1995, Archives of biochemistry and biophysics.

[53]  George Perry,et al.  Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease , 2000 .

[54]  A. Palmer,et al.  Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease , 1994, Brain Research.

[55]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[56]  N. Delanty,et al.  Risk of Alzheimer's disease and duration of NSAID use , 1998, Neurology.

[57]  George Perry,et al.  RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease , 1999, The Journal of Neuroscience.

[58]  D. Perl,et al.  Evidence of neuronal oxidative damage in Alzheimer's disease. , 1996, The American journal of pathology.

[59]  J. Overmier,et al.  Present Imperfect: A Critical Review of Animal Models of the Mnemonic Impairments in Alzheimer's Disease , 1997, Neuroscience & Biobehavioral Reviews.

[60]  K. Herrup,et al.  Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain , 1998, The Journal of Neuroscience.

[61]  M. Smith,et al.  Abortive oncogeny and cell cycle-mediated events in Alzheimer disease. , 2000, Progress in cell cycle research.

[62]  R. Kauppinen,et al.  Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Hilkka Soininen,et al.  Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers , 2005, Annals of neurology.

[64]  M. Staufenbiel,et al.  Amyloid deposition in APP23 mice is associated with the expression of cyclins in astrocytes but not in neurons , 2003, Acta Neuropathologica.

[65]  S. Tsuji,et al.  Apolipoprotein E allele–dependent antioxidant activity in brains with Alzheimer’s disease , 2000, Neurology.

[66]  F. Schmitt,et al.  Evidence of increased oxidative damage in subjects with mild cognitive impairment , 2005, Neurology.

[67]  A. Smith,et al.  Cell cycle markers in the hippocampus in Alzheimer’s disease , 1997, Acta Neuropathologica.

[68]  Mark A. Smith,et al.  4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.

[69]  Joseph S. Beckman,et al.  Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.

[70]  R. Tyrrell,et al.  Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Xiongwei Zhu,et al.  Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease , 2001, Journal of neurochemistry.

[72]  D. Butterfield,et al.  Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment , 2006, Neuroscience Letters.

[73]  R. Lathe,et al.  Comparative proteomic analysis using samples obtained with laser microdissection and saturation dye labelling , 2005, Proteomics.

[74]  U. Gärtner,et al.  Expression of the cyclin‐dependent kinase inhibitor p16 in Alzheimer's disease , 1996, Neuroreport.

[75]  H. Orr,et al.  Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice , 1992, Neuron.

[76]  W. Markesbery,et al.  The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. , 2002, Nitric oxide : biology and chemistry.

[77]  B. Ghetti,et al.  Cell-cycle markers in a transgenic mouse model of human tauopathy: increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1. , 2006, The American journal of pathology.

[78]  Karl Herrup,et al.  Neuronal Cell Death Is Preceded by Cell Cycle Events at All Stages of Alzheimer's Disease , 2003, The Journal of Neuroscience.

[79]  W. Surewicz,et al.  Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal. , 1997, Chemical research in toxicology.

[80]  W. Markesbery,et al.  The Nitration Product 5-Nitro-γ-tocopherol Is Increased in the Alzheimer Brain , 2002 .

[81]  A. Berns,et al.  Requirement for a functional Rb-1 gene in murine development , 1992, Nature.

[82]  D. Allan Butterfield,et al.  Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease , 2006, Neurobiology of Disease.

[83]  P. Davies,et al.  Mitotic mechanisms in Alzheimer's disease? , 1996, The Journal of cell biology.

[84]  N Howell,et al.  Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[85]  K. Herrup,et al.  Ectopic Cell Cycle Events Link Human Alzheimer's Disease and Amyloid Precursor Protein Transgenic Mouse Models , 2006, The Journal of Neuroscience.

[86]  J. Trojanowski,et al.  Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. , 2002, Archives of neurology.

[87]  G. Perry,et al.  Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome , 2000 .

[88]  Xiongwei Zhu,et al.  Cell cycle events in neurons. Proliferation or death? , 1999, The American journal of pathology.

[89]  J. Trojanowski,et al.  Increased F2‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[90]  R. Heumann,et al.  Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. II. Cytoskeletal proteins and dendritic morphology , 2001, Neuroscience.

[91]  L. Arckens,et al.  Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1. , 2004, Brain research. Molecular brain research.

[92]  A. Smith,et al.  Expression of cell division markers in the hippocampus in Alzheimer’s disease and other neurodegenerative conditions , 1997, Acta Neuropathologica.

[93]  Virginia M. Y. Lee,et al.  Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis , 2001, The Journal of Neuroscience.

[94]  R. Ravid,et al.  Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.

[95]  G. Perry,et al.  A suicide note from Alzheimer disease neurons? , 1998, Nature Medicine.

[96]  D. Dickson,et al.  Mitotic phosphoepitopes precede paired helical filaments in Alzheimer’s disease , 1998, Neurobiology of Aging.

[97]  A. Trumpp,et al.  Conditional Mutation of Rb Causes Cell Cycle Defects without Apoptosis in the Central Nervous System , 2003, Molecular and Cellular Biology.

[98]  M. Mattson,et al.  beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. , 1994, Biochemical and biophysical research communications.

[99]  L. Mucke,et al.  Reduction in Mitochondrial Superoxide Dismutase Modulates Alzheimer's Disease-Like Pathology and Accelerates the Onset of Behavioral Changes in Human Amyloid Precursor Protein Transgenic Mice , 2006, The Journal of Neuroscience.

[100]  R. Heumann,et al.  Induction of p21ras in Alzheimer pathology. , 1995, Neuroreport.

[101]  G. Perry,et al.  Advanced Maillard reaction end products are associated with Alzheimer disease pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[102]  N. Mangini,et al.  Unscheduled DNA replication precedes apoptosis of photoreceptors expressing SV40 T antigen. , 1997, Experimental eye research.

[103]  M. Mattson,et al.  β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease , 1994 .

[104]  Hirotaka Yoshida,et al.  Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein , 2002, The Journal of Neuroscience.

[105]  Naruhiko Sahara,et al.  Phosphorylated p38MAPK specific antibodies cross‐react with sarkosyl‐insoluble hyperphosphorylated tau proteins , 2004, Journal of neurochemistry.

[106]  J. Trojanowski,et al.  Increased 8,12‐iso‐iPF2α‐VI in Alzheimer's disease: Correlation of a noninvasive index of lipid peroxidation with disease severity , 2000, Annals of neurology.

[107]  David S. Park,et al.  G1/S Cell Cycle Blockers and Inhibitors of Cyclin-Dependent Kinases Suppress Camptothecin-Induced Neuronal Apoptosis , 1997, The Journal of Neuroscience.

[108]  D. Selkoe,et al.  Alzheimer's Disease--Genotypes, Phenotype, and Treatments , 1997, Science.

[109]  U. Gärtner,et al.  Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration , 1999, Neuroscience.

[110]  S Shimohama,et al.  Activation of MKK6, an upstream activator of p38, in Alzheimer's disease , 2001, Journal of neurochemistry.

[111]  M. Beal,et al.  Oxidative damage in Alzheimer's , 1996, Nature.

[112]  D. Selkoe.  Alzheimer's disease: genotypes, phenotypes, and treatments. , 1997, Science.

[113]  A. Schmidt,et al.  RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. , 1996, Nature.

[114]  Mark A. Smith,et al.  Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease , 1995, Journal of neurochemistry.

[115]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[116]  Xiongwei Zhu,et al.  Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP‐1‐associated regulator of cyclin B, in Alzheimer's disease , 2004, Journal of neuroscience research.

[117]  R. Weinberg,et al.  Effects of an Rb mutation in the mouse , 1992, Nature.

[118]  R. Kauppinen,et al.  β-Amyloid precursor protein transgenic mice that harbor diffuse Aβ deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[119]  K. Herrup,et al.  DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease , 2001, The Journal of Neuroscience.

[120]  J. Trojanowski,et al.  Altered Tau and Neurofilament Proteins in Neuro‐Degenerative Diseases: Diagnostic Implications for Alzheimer's Disease and Lewy Body Dementias , 1993, Brain pathology.

[121]  J. Trojanowski,et al.  Traumatic brain injury in young, amyloid‐β peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Aβ deposition during aging , 1999 .

[122]  J Pierard,et al.  Amyloid , 2023, Arthritis and rheumatism.

[123]  G. Perry,et al.  Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. , 2000, Journal of neuropathology and experimental neurology.

[124]  C. Colton,et al.  Production of superoxide anions by a CNS macrophage, the microglia , 1987, FEBS letters.

[125]  T. Rushmore,et al.  Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[126]  P. Davies,et al.  Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms , 2003, Journal of neurochemistry.

[127]  M. Smith,et al.  Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. , 1997, The American journal of pathology.

[128]  K. Davies,et al.  Transient adaptation of oxidative stress in mammalian cells. , 1995, Archives of biochemistry and biophysics.

[129]  G. Jicha,et al.  Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain , 1997, The Journal of Neuroscience.

[130]  Xiongwei Zhu,et al.  Involvement of Oxidative Stress in Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.

[131]  G. Perry,et al.  Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. , 1994, The American journal of pathology.

[132]  R. Nitsch,et al.  Age-Dependent Neurodegeneration and Alzheimer-Amyloid Plaque Formation in Transgenic Drosophila , 2004, The Journal of Neuroscience.

[133]  T. Jacks,et al.  Cell‐autonomous and non‐cell‐autonomous functions of the Rb tumor suppressor in developing central nervous system , 2001, The EMBO journal.

[134]  M. Tabaton,et al.  Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.

[135]  George Perry,et al.  Is oxidative damage central to the pathogenesis of Alzheimer disease? , 1998, Acta neurologica Belgica.

[136]  G. Pasinetti.  Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: The role of the complement system , 1996, Neurobiology of Aging.